The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
Collaboration on Neuroimmunology: Question, Understand, Educate, Restore - The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
Sponsor: University of Texas Southwestern Medical Center
A observational or N/A phase clinical study on Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder, this trial is ongoing. The trial is conducted by University of Texas Southwestern Medical Center and has accumulated 21 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
21 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2025 — Feb 2026 [monthly]
Recruiting
-
Nov 2024 — Sep 2025 [monthly]
Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 16 earlier versions
-
Oct 2023 — Jul 2024 [monthly]
Recruiting
-
Jun 2023 — Oct 2023 [monthly]
Recruiting
-
Jun 2022 — Jun 2023 [monthly]
Recruiting
-
Dec 2021 — Jun 2022 [monthly]
Recruiting
-
Jun 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Jun 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2020 — Nov 2020 [monthly]
Recruiting
-
Dec 2019 — Jun 2020 [monthly]
Recruiting
-
Dec 2018 — Dec 2019 [monthly]
Recruiting
-
Jun 2018 — Dec 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jul 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
Jun 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .